Rheumatoid Arthritis: Early Diagnosis and Treatment
Emphasizes the importance of early intervention in RA with focus on pharmacologic treatments of RA. Detailed information on the various medications employed in treatment, including corticosteroids, NSAIDs, DMARDs, biologic agents, and combination therapy, is reviewed, including evidence-based data on efficacy, safety, side effects, and monitoring requirements. Clinical evaluation is presented, including lab findings, joint scoring, diagnostic criteria, and radiographic outcomes. Surgical options and the management of advanced RA are discussed.
Avis des internautes - Rédiger un commentaire
Aucun commentaire n'a été trouvé aux emplacements habituels.
abatacept ACR20 response active RA adalimumab adverse events agents aggressive anakinra Ann Rheum anti-TNF arthritis patients Arthritis Rheum assessed beneﬁts biologic cells certolizumab pegol chronic clinical trials combination DMARD combination therapy compared corticosteroids cyclosporine cytokines deﬁned diagnosis disease activity disease duration DMARD DMARD therapy dose double-blind drug early RA patients early rheumatoid arthritis effective erosions etanercept Figure ﬁndings ﬁrst golimumab hepatic increased inﬂammation infliximab inhibition initial joint count lymphoma methotrexate mg/kg monoclonal antibody monotherapy necrosis factor new-onset NSAIDs onset outcomes pain patient-years patients receiving patients treated patients with active patients with early patients with RA patients with rheumatoid placebo placebo-controlled polyarthritis prednisone psoriatic arthritis radiographic radiographic progression randomized receptor referral remission Rheum rheumatoid arthritis rheumatoid nodules Rheumatol rheumatologists risk rituximab rofecoxib safety serious infections serum signiﬁcant signiﬁcantly swollen joints symptoms synovial T-cell TNF inhibitors tocilizumab toxicity treatment week 24